Figure 2From: Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicityReverse transcription-polymerase chain reaction analysis showing a strong decrease in clusterin RNA after treatment with antisense oligodeoxynucleotides to clusterin (ODNclu) in the MDA-MB-231 (a) and MCF-7 (b) cell lines. C, basal expression; MW, molecular weight; ODNc, control oligonucleotide.Back to article page